| |
| |
|
| Insider
Information: |
Barbo William D |
| Relationship: |
Corporate Executive VP... |
| City: |
Wilmington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,035 |
|
|
Indirect Shares
|
22,879 |
|
|
| Direct
Value |
$906,866 |
|
|
|
Indirect Value
|
$5,142,055 |
|
|
| Total
Shares |
26,914 |
|
|
| Total
Value |
$6,048,922 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 163.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Charles River Laboratories Inter... |
CRL |
Corporate Executive VP... |
2024-02-22 |
4,035 |
2024-02-22 |
22,879 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCOOf |
• – – |
2016-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,465 |
|
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2017-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,249 |
25,714 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,899 |
24,662 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2018-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,511 |
23,435 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2018-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,840 |
21,996 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,209 |
29,189 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,585 |
29,330 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,745 |
29,676 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2020-03-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,151 |
5,899 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2020-03-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,151 |
12,151 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,815 |
18,050 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2020-10-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
180 |
11,971 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,862 |
17,761 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,154 |
5,899 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,154 |
16,975 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,157 |
18,132 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,157 |
3,818 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,006 |
4,824 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
252 |
4,371 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-06-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
252 |
12,312 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-12-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
400 |
11,912 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,273 |
14,644 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,178 |
4,371 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-02-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
6,178 |
18,090 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-03-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
754 |
18,844 |
0 |
- |
|
96 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
